Cornell helps develop pest-resistant eggplant, the first genetically modified food crop in South Asia
The engineered eggplant expresses a natural insecticide derived from the bacteria Bacillus thuringiensis (Bt), making it resistant to the fruit and shoot borer (FSB), a highly destructive pest. The tiny larvae account for up to 40 percent of eggplant crop losses each year in India, Bangladesh and the Philippines, and other areas of South and Southeast Asia.
The work on the resistant eggplant is part of the Agricultural Biotechnology Support Project (ABSP) II, which is funded by the U.S. Agency for International Development and administered by Cornell in partnership with Sathguru, a firm associated with Cornell's College of Agriculture and Life Sciences (CALS).
Cornell researchers from plant breeding, entomology, molecular biology, applied economics, communication, international programs and the Cornell Center for Technology Enterprise and Commercialization began collaborating on the development of the Bt eggplant in 2002. Another partner, Maharashtra Hybrid Seeds, is on schedule to commercialize the genetically modified fruit by 2009.
All the safety tests for the Bt eggplant have been conducted in India, starting in greenhouses and now moving to large-scale field trials. The eggplant has been found to be nontoxic to fish, chickens, rabbits, goats, rats and cattle as well as nonallergenic. Ongoing tests will examine such questions as whether the plant will continue to resist FSB in the field and for how long; whether the Bt eggplant cross pollinates with other eggplants in the field and how far the Bt plants should be from other eggplant fields; whether nontarget insect populations are affected in the long term; and how yields compare with those of other eggplant varieties.
It is estimated that the Bt eggplant will reduce insecticide use by 30 percent while doubling the yield of marketable fruit (although eggplant is eaten as a vegetable).
Most read news
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.